Literature DB >> 30869744

Comprehensive evaluation of ubiquitous promoters suitable for the generation of transgenic cynomolgus monkeys†.

Yasunari Seita1, Tomoyuki Tsukiyama1,2, Takuya Azami1, Kenichi Kobayashi1,3, Chizuru Iwatani1, Hideaki Tsuchiya1, Masataka Nakaya1, Hideyuki Tanabe4, Seiji Hitoshi5, Hiroyuki Miyoshi6, Shinichiro Nakamura1, Akihiro Kawauchi3, Masatsugu Ema1,2,7.   

Abstract

Nonhuman primates (NHPs) are considered to be the most valuable models for human transgenic (Tg) research into disease because human pathology is more closely recapitulated in NHPs than rodents. Previous studies have reported the generation of Tg NHPs that ubiquitously overexpress a transgene using various promoters, but it is not yet clear which promoter is most suitable for the generation of NHPs overexpressing a transgene ubiquitously and persistently in various tissues. To clarify this issue, we evaluated four putative ubiquitous promoters, cytomegalovirus (CMV) immediate-early enhancer and chicken beta-actin (CAG), elongation factor 1α (EF1α), ubiquitin C (UbC), and CMV, using an in vitro differentiation system of cynomolgus monkey embryonic stem cells (ESCs). While the EF1α promoter drove Tg expression more strongly than the other promoters in undifferentiated pluripotent ESCs, the CAG promoter was more effective in differentiated cells such as embryoid bodies and ESC-derived neurons. When the CAG and EF1α promoters were used to generate green fluorescent protein (GFP)-expressing Tg monkeys, the CAG promoter drove GFP expression in skin and hematopoietic tissues more strongly than in ΕF1α-GFP Tg monkeys. Notably, the EF1α promoter underwent more silencing in both ESCs and Tg monkeys. Thus, the CAG promoter appears to be the most suitable for ubiquitous and stable expression of transgenes in the differentiated tissues of Tg cynomolgus monkeys and appropriate for the establishment of human disease models.
© The Author(s) 2019. Published by Oxford University Press on behalf of Society for the Study of Reproduction.

Entities:  

Keywords:  blastocyst; differentiation; embryonic stem cells; intracytoplasmic sperm injection (ICSI); primates; zygote

Year:  2019        PMID: 30869744     DOI: 10.1093/biolre/ioz040

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

Review 1.  Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges.

Authors:  Jenna K Schmidt; Kathryn M Jones; Trevor Van Vleck; Marina E Emborg
Journal:  Sci Transl Med       Date:  2022-03-02       Impact factor: 19.319

Review 2.  Non-human primates as a model for human development.

Authors:  Tomonori Nakamura; Kohei Fujiwara; Mitinori Saitou; Tomoyuki Tsukiyama
Journal:  Stem Cell Reports       Date:  2021-05-11       Impact factor: 7.765

3.  Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein.

Authors:  Yasunari Seita; Toshifumi Morimura; Naoki Watanabe; Chizuru Iwatani; Hideaki Tsuchiya; Shinichiro Nakamura; Toshiharu Suzuki; Daijiro Yanagisawa; Tomoyuki Tsukiyama; Masataka Nakaya; Eiichi Okamura; Masanaga Muto; Masatsugu Ema; Masaki Nishimura; Ikuo Tooyama
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 4.  Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation.

Authors:  Leila Haery; Benjamin E Deverman; Katherine S Matho; Ali Cetin; Kenton Woodard; Connie Cepko; Karen I Guerin; Meghan A Rego; Ina Ersing; Susanna M Bachle; Joanne Kamens; Melina Fan
Journal:  Front Neuroanat       Date:  2019-11-26       Impact factor: 3.856

5.  The human EF1a promoter does not provide expression of the transgene in mice.

Authors:  Nariman Battulin; Alexey Korablev; Anastasia Ryzhkova; Alexander Smirnov; Evelyn Kabirova; Anna Khabarova; Timofey Lagunov; Irina Serova; Oleg Serov
Journal:  Transgenic Res       Date:  2022-08-12       Impact factor: 3.145

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.